CADLCandel Therapeutics, Inc.

$9.66+72% 1Y

Is it growing?

Is CADL growing?

Candel Therapeutics, Inc. has grown revenue 0.00% a year over three years and 0.00% a year over five.

0.00%

Revenue growth, 3-year annual rate · Biotechnology median +17% · shrinking · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate
0.00%

Revenue growth, 5-year rate · 0.00% over three · growth has slowed since the five-year average

Years of annual history on file
6

Years of annual history on file · FY2020 to FY2025, as filed

Details›
Revenue FY2021
$125K
Revenue FY2022
$125K

Annual income statements as filed with the SEC.